Stay updated on DCC-2618 vs Placebo in Advanced GIST Patients Clinical Trial
Sign up to get notified when there's something new on the DCC-2618 vs Placebo in Advanced GIST Patients Clinical Trial page.

Latest updates to the DCC-2618 vs Placebo in Advanced GIST Patients Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe two screenshots show the same study page with no changes to core information (title, conditions, locations, enrollment, eligibility, or outcomes). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check17 days agoNo Change Detected
- Check38 days agoChange DetectedUpdated version to v3.2.0 and added a government operating-status notice; removed the Genetic and Rare Diseases Information Center resource for Gastrointestinal stromal tumor.SummaryDifference3%

- Check46 days agoChange DetectedSummary: The page is updated to revision v3.1.0 and several MedlinePlus drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) are removed, indicating content reduction in pharmaceutical safety areas.SummaryDifference0.4%

- Check60 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.SummaryDifference0.2%

- Check67 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%

- Check74 days agoChange DetectedThe web page has been updated to include new drug information for Ripretinib and related topics, while some location details and previous terminology have been removed.SummaryDifference3%

Stay in the know with updates to DCC-2618 vs Placebo in Advanced GIST Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DCC-2618 vs Placebo in Advanced GIST Patients Clinical Trial page.